Introduction
Over the past three decades research into quality of life (QOL) has become increasingly prominent. It has allowed for assessment of the overall impact of diseases and medical treatments on an individual's life from the patient's point of view. The rationale of QOL research was that tracking health-related quality of life (HRQOL) in different populations can identify subgroups with poor physical or mental health, which are often associated with chronic diseases, and can help guide policies or interventions to improve the health status. 1, 2 The HRQOL research developed two main types of instruments: (1) Generic scales, used for comparisons of health status between different diseases and applicable to virtually all people, and (2) Disease-specific scales, used to assess health status in individuals with particular diseases or conditions. 2 One of the most widely used generic QOL scales is Short Form Health Survey (SF-36). 3 Epilepsy is a chronic disease. It adversely affects both physical and psychosocial functioning in manifold ways even when seizures are controlled. The need to better understand and measure the distress of people with epilepsy (PWE) stimulated the development of many HRQOL scales. As recently stated, QOL studies in epilepsy should preferably employ scales with known psychometric properties (reliability, validity and responsiveness), widespread in use (used by more than one author, and used in more than five studies) and specific to epilepsy, assessing at least side effects of medication and impact of severity/frequency of seizures. 4 purpose is pre-surgical evaluation 9 ; and (6) Liverpool Health Related Quality of Life Battery (Liverpool HRQOL). 10 The QOLIE-31 was originally created in the United States of America (USA) as the shortened form of the QOLIE-89. It was designed to serve as an epilepsy-specific instrument for rapid evaluation of the major HRQOL domains that are of concern to adults with epilepsy. 6 The psychometric properties of the original USA version have been assessed in detail, 6 and the QOLIE-31 has been demonstrated to be a responsive measure with respect to seizure frequency and self-reported overall condition. 11 The instrument has been and is currently used in numerous clinical studies, [12] [13] [14] [15] becoming one of the most frequently used epilepsyspecific HRQOL scales. Since QOLIE-31 was initially developed for use in the context of USA culture, translation and cultural adaptation are necessary in order to make it usable for assessing QOL in other cultures. Recent studies evaluated the psychometric properties of the QOLIE-31 in several different linguistic and cultural groups, using among others Spanish, German, French, Italian, Greek, Portuguese and Czechlanguage versions of QOLIE-31. [16] [17] [18] [19] [20] [21] [22] Specific psychometric data are lacking for the Serbian-language version of the QOLIE-31. In this paper, we report the data from a validation study on the translated and culturally adapted Serbian version of QOLIE-31. 23 
Method

Cross-cultural translation
One of the authors (ZM) obtained the permission to translate QOLIE-31 into Serbian from the QOLIE Development Group (J. Cramer). The original English version of the QOLIE-31 was translated into Serbian by a bilingual translator independent of the study itself. This first Serbian version was subsequently backtranslated and differences from original wording in the USA version were discussed by a panel of experts including neurologists and English and Serbian language teachers. They used content correspondence as the main guideline when agreeing on final item wording. The layout and the images of the Serbian version were identical to the original instrument. The final version was tested in a pilot study that included 30 adult PWE, which confirmed a high level of item acceptance and comprehension. This preliminary study confirmed that the Serbian-language version was equivalent in content and meaning to the original American version.
Study population
All adult PWE who consecutively attended regular appointments at the Department of Epilepsy and Clinical Neurophysiology of The Institute of Mental Health in Belgrade were recruited for participation in the study. PWE aged 18-65 years with a proven diagnosis either of partial epilepsy or of primarily generalized epilepsy 24, 25 and good compliance with antiepileptic drugs were eligible if they were able to understand and complete the questionnaires. PWE gave informed consent prior to participating in the study. Exclusion criteria were: presence of a significant psychiatric disorder, progressive neurological disease, and concomitant use of neuroleptic drugs, cranial trauma or craniotomy during the last year. Study was approved by the Ethical Committee of the Medical School at the University of Belgrade.
Questionnaires
We applied three scales: (1) the Serbian translation of the QOLIE-31 used in the original report by Cramer et al., 6 (2) the SF-36 3 and (3) the Neurotoxicity scale-II. 26 The latter two scales were used to assess the criterion validity of the Serbian-language version of QOLIE-31. Socio-demographic data were obtained using a semi-structured interview. Clinical characteristics of epilepsy were obtained from the medical records of patients. 13, 19, 20, 27, 28) . A scoring system is available for each item (raw score from 0 to 3 or from 0 to 6) and is calculated for each scale. The raw values were converted to 0-100 scores, with higher values reflecting better quality of life (from 0, the worst HRQOL, to 100, the best). The scores are calculated for each domain and the overall score is obtained by using a weighted average of the multi-item scale scores.
27
SF-36 is the most widely evaluated tool for measuring patientreported outcomes. As documented in several thousand publications, this generic health survey can be used across age, disease and treatment group and is appropriate for a wide variety of applications. It yields an 8-domain profile including: Bodily pain, General health, Mental health, Physical functioning, Role emotional, Role physical, Social functioning and Vitality. All questions are scored on a scale from 0 to 100, with 100 representing the highest level of functioning possible. Aggregate scores are compiled as a percentage of the total points possible, using the RAND scoring table SF-36.
3, 28 We applied version 2 (SF-36v2)-Serbian-language translation. 3 Scoring and calculation of scales were performed by using the Ware's survey manual.
28
Neurotoxicity scale-II (NTS-II) was devised as a patient-based report scale to assess the adverse effects of antiepileptic drugs on cognitive function. 26 The scale is comprised of six cognitive domains: fatigue, slowing, memory, concentration, motor coordination and language. The most valid primary outcome measure is the overall score (from 0 to 72) that renders a global ('all or nothing') evaluation indicating whether a subject experiences cognitive impairment and associates this with the antiepileptic drug treatment. Its validation suggested the maximal applicability as a screening instrument in outpatient practice and in phase II and IIIa drug trials.
Methods for discriminative power, reliability and validity assessment
Discriminative power was assessed by checking deviations of scores from the normal distribution for the whole scale and for the subscales on QOLIE-31. Deviations were tested by KolmogorovSmirnov test and by coefficients of distortion (Skewness and Kurtosis).
Assessment of reliability involved the calculations of internal reliability and Test-retest reliability (repeatability). [29] [30] [31] Internal consistency was assessed with Cronbach's a coefficient. Conventionally, a value above 0.70 is regarded as acceptable, values above 0.8 are considered good, and values above 0.9 are thought to be an excellent indicator of internal consistency. 29 Repeatability was evaluated by retest measurement after a period of 2-3 weeks from the initial testing in a subgroup of 110 PWE whose health status did not undergo any changes between the first and the second assessment. Construct validity of QOLIE-31 was assessed by exploratory factor analysis using a method of principal component analysis with orthogonal varimax rotation. Plausible factors were extracted using the Guttmann-Kaiser Criterion or Kattel's scatter diagram. Additionally, we used multitrait-scaling analysis for assessing construct validity. [29] [30] [31] Item-scale correlations were assessed by
Pearson's correlation coefficients, considering the level of at least 0.4 as an acceptable correlation coefficient. Lastly, for assessing the construct validity of the QOLIE-31 questionnaire we also used the method of known-groups validation. We hypothesized that: (1) QOLIE-31 scores should be lower (i.e., worse QOL) in PWE with a higher seizure severity (a composite measure based on seizure frequency and seizure types), 32, 33 (2) QOLIE-31 scores should be significantly higher (i.e., better QOL) in PWE with idiopathic epilepsy than in PWE belonging to cryptogenic or symptomatic epilepsy subgroups, and (3) that differences in educational and employment status will significantly affect QOLIE-31 scores. These hypotheses were tested using the analysis of variance (ANOVA).
To assess criterion validity we determined the correlations of instrument scores with external measures on other similar instruments (SF-36 and Neurotoxicity scale-II). The relationship between scales of QOLIE-31 and SF-36 was tested using Pearson's correlation coefficients and canonical correlation analysis. Strong correlations were expected between domains and scales with the same content, for example between the overall scores of the QOLIE-31 Serbian-language version and SF-36. In addition, a strong negative correlation was expected between QOLIE-31 and Neurotoxicity scale-II.
As a criterion for rejecting the null hypothesis we used a level of significance of 5% (p < 0.05). For psychometric and statistical analysis we used SPSS for Windows (Version 12.0, SPSS Inc., Chicago, IL, USA).
Results
Socio-demographic sample characteristics
The sample consisted of 203 patients, 118 women (58.1%) and 85 men (41.9%) with a mean age of 37.93 years (SD AE 13.64; range 18-65). Around half of patients (N = 110, 54.18%) were re-tested after a 2-3 weeks interval. The socio-demographic characteristics are shown in Table 1 and clinical characteristics in Table 2 .
Descriptive statistics and discriminative power
Missing items. For each item there were missing items, mostly this ranged from a minimum of 1 to a maximum of 6, 1.3% on average. In the domain Social function, item 20 (driving) was missing in 55 (27.1%) and item 27 (work limitations) in 7 (3.4%). After the exclusion of the item ''driving'' the number of fully answered questionnaires increased to 96.4%. According to the Scoring Manual, 27 missing values can be overcome by calculating scale scores in a different way: the total sum of valid item scores is divided by the number of items with valid responses in the scale. Summary of descriptive statistics of QOLIE-31 scores are presented in Table 3 . Mean overall score was 70.64 AE 17.74. Discriminative power testing showed that domains Seizure worry and Overall quality of life showed an almost normal distribution while the remaining scales showed positive skewness, i.e., distribution with an asymmetric tail extending toward more positive values. This is particularly true for Emotional well-being, Energy/Fatigue, Cognitive, Medication effects and Social function (Table 4) .
Reliability
Internal consistency. As depicted in Table 3, calculation of Cronbach's a demonstrated a good internal consistency of the overall scale (0.94) and of all of its specific dimensions, especially for Emotional well-being (0.86). On the other hand, internal consistency was lower although still acceptable for Overall quality of life-0.72 (only two items), and for Social function-0.75 (item 20-27.1% missing).
Repeatability. Test-retest demonstrated that QOLIE-31 was reliable since Pearson's correlation values were moderately highly or highly significant for each domain score, ranging from 0.606 to 0.797, and 0.829 for the overall score (Table 3) .
Validity
Construct validity. Factor analysis on 30 items led to the extraction of 6 factors with eigenvalues >1, according to Guttmann-Kaiser Criteria (Table 5 ). Katel's scatter diagram indicated that a single factor could be extracted with high loadings on all items. After varimax matrix rotation six factors were extracted. Second factor corresponds to the Cognitive domain (5/ 6 items) and third factor to Seizure worry (5/5) domain of the original questionnaire. First factor was more heterogeneous, containing high loadings from all items from the Emotional wellbeing domain, all items from the Energy/Fatigue domain and the Overall quality of life domain. Fourth factor included two items from Social function and two from Medication effects domains, fifth factor had one item from Social function and one from Cognitive domains. Sixth factor contained a single item from Social function: item 20 (driving) which had a high rate of missing values (see Appendix A). Thus, exploratory factor analysis did not extract solutions that matched those obtained from originally designed domains
Since previous research had shown some stability of proposed scales in non-English versions we used multitrait-scaling analysis as an additional method to check construct validity. Item-scale correlations were calculated for the 30 items that form the seven original domains (Appendix B). In every instance, individual items correlated more significantly with the domain on which that item loaded than with other domains. Item-scale correlations were uniformly very high for all domains, including: Seizure worry Table 6 ). The only domain that did not show differences was Medication effects. Using Scheffe post hoc tests, we showed that only two extreme groups differed on the six domains. The lowest scores were found in PWE from the high seizure severity group (mean OS 58.06), and highest scores in PWE with controlled seizures (mean OS 72.50). Differences between PWE with idiopathic, cryptogenic or symptomatic etiology were again evident in six QOLIE-31 domains: Seizure worry, Overall quality of life, Emotional well-being, Energy/Fatigue, Cognitive, Social function and on overall scale score, except in Medication effects subscale (Table 6 ). Scores were highest in PWE with idiopathic epilepsy (mean OS 76.93) and lowest in those with symptomatic epilepsy (mean OS 67.62). Different employment status was associated with significant differences in Overall quality of life domain, Emotional well-being, Social function and in Overall score (Table  6 ). Scheffe post hoc tests differentiated two subgroups with extreme scores. The highest one comprised students (mean OS 78.68), and the lowest one retired PWE (mean OS 61.59). Different educational levels affected only the Emotional wellbeing domain with lowest scores in PWE with an elementary school diploma (mean overall score 64.27) and highest scores in students (mean OS 78.17) ( Table 6 ).
Criterion validity. Pearson's correlation coefficients between QOLIE-31 and SF-36 subscales (Table 7) were significant and high for all domains, except for QOLIE-31 Seizure worry and Medication effects (r < 0.4). This finding could suggest some specificity of these domains. Canonic correlation analysis between QOLIE-31 and SF-36 revealed two significant canonical functions. Pearson's correlation coefficient between QOLIE-31 overall score and NTS-II overall score was highly negative and significant (r = À0.730, p < 0.001). Canonical correlation analysis between domains showed two significant canonical functions. 
Discussion
Reliability of Serbian version
The Serbian QOLIE-31 is interdependent and homogenous in terms of the concepts it measures, as indicated by the high Cronbach's a coefficients (0.94 for overall score), comparable with original US version (0.93 for overall score), 6 as well as with Spanish (0.92), 16 Italian (0.88), 19 and Greek version (0.92), 20 and much higher than 0.68 in Czech study 22 where it was yet considered to be acceptable. The internal consistency was lower for Overall quality of life (0.72) than for other domains as it contained only two items.
Cronbach's a is dependent on both the magnitude of the inter-item correlations and on the number of items contained in the scale. 29 If the scale does not have many items it may be very difficult to achieve adequate internal consistency. Our finding is similar to the results of the US, 6 Italian 19 and Czech studies 22 but higher than in the Spanish 16 and Greek studies.
20
The test-retest correlation coefficients of the QOLIE-31 Serbianlanguage version (0.83 for overall score) was lower than those reported in US (0.89), 6 Spanish (0.90) 16 and Greek studies (0.92) 20 but similar to the score obtained in the German study (0.80). 17 Missing values in our study were frequent only for the items ''driving'' (27.1%) and ''working limitations'' (3.4%) from the Social functioning domain. In the Italian study 19 the rate of missing responses for ''driving'' (41.9%) and for ''working limitations'' (33.4%) was even higher. In the Czech study 22 the responses for ''driving'' were missing in 33% of the 221 patients. The majority of patients included in our study did not drive and many of them were unemployed (25.1%). Therefore, these findings probably reflect life restrictions caused by epilepsy. Intercultural differences may also contribute to the differences in missing responses to the item ''driving''. It was suggested that vital importance of driving as a part of social life may differ in various cultures. 22 The use of public transport (bus or train) to commute to work or for traveling may be more acceptable in some countries than in others. Additional comments provided by patients may serve to overcome the problems caused by missing values with the items ''driving'' and ''working'' in the Social functioning domain. A further study could investigate whether or not it would be useful to add ''problems with travelling or transport'' to the item ''driving'' 22 in order to make it more comprehensive or informative.
Validity of the Serbian-language version
The factorial structure of the Serbian-language version of QOLIE-31 was similar to that of the US version reported by Cramer et al., 6 as well as of German 17 and Czech 22 versions. The first factor was heterogeneous, consisting of Emotional wellbeing, Overall quality of life and Energy/Fatigue in our, US and German study; in the Czech study it contained Emotional wellbeing and Energy/Fatigue. This factor appears to represent mood and overall quality of life. However, minor differences exist: in the study of Cramer et al., 6 Medication effects is one single factor while in our study it spreads over two factors: two items load on one factor together with two Social function items, but the third item is tied to the Seizure worry factor. A probable explanation is that PWE with good compliance with antiepileptic drugs such as those included in our study had relatively low mean overall score on the Neurotoxicity scale- Multitrait-scaling analysis showed satisfactory construct validity of QOLIE-31, since all items showed stronger correlations with scales which they construct than with other scales. Together with good internal consistency obtained in reliability analysis, these findings allow us to conclude that QOLIE-31 has satisfactory construct validity. Nevertheless, it should be noted that its structure cannot be confirmed by factor analysis and that it seems to vary across different versions. One probable reason might be the specificity of populations investigated in different studies.
We further demonstrated good construct validity of the Serbian-language version of QOLIE-31 by showing that seizure severity and etiology of epilepsy influence all domains of QOLIE-31 except the Medication effect scale. The best QOL was reported by PWE without seizures in the past year and by PWE with an idiopathic etiology. Inversely, QOL was worst in the subgroup of PWE with high seizure severity scores and with symptomatic etiology. The associations between QOLIE-31 and socio-demographic variables were demonstrated as well. Employment status was associated with Overall quality of life, Emotional well-being and Social function scores while education level was associated with Emotional well-being scores. These results suggest that QOLIE-31 includes a wide spectrum of concerns facing PWE, as confirmed in many previous clinical studies. 6, [16] [17] [18] [19] [20] [21] [22] 33, 34 Further cross-cultural comparisons between populations with epilepsy could provide more useful information about the impact of epilepsy and its' associations with other factors in various countries worldwide.
All QOLIE-31 dimensions in our study population showed a high correlation with SF-36 that can be explained by the fact that these domains contain some practically identical items. These findings provide a further strong argument in favor of good criterion validity of the Serbian-language version of QOLIE-31 especially since the canonic correlation between the scales is high (rho = 0.898). 35 Likewise, in the study of Beghi et al., 19 comparable correlations were found between QOLIE-31 Overall QOL and SF-36 General health and Vitality; Energy-Fatigue with SF-36 Vitality; and Emotional well-being with SF-36 Mental health. Lowest correlations of Medications effect and Seizure worry domains of QOLIE-31 with the general HRQOL questionnaire SF-36 suggest the specificity of these domains for epilepsy. A weak relation of these domains of QOLIE-31 with general aspects of HRQOL is also evident in the study of Beghi et al. 19 As expected, QOLIE-31 and NTS-II scores were highly correlated since they may be both related to the seizures and medications effects predominantly affecting the central nervous system. Similarly, Cramer et al. showed high correlations between neurotoxicity scores and QOLIE-31. 6 The assessment of discriminative power of the Serbian version of QOLIE-31 disclosed that almost all domains were skewed toward higher scores. This resulted in a somewhat higher mean overall score in our study (70.67 AE 17.74) than in the original American version (63 AE 16). This difference is probably due to the inclusion of 61 (30%) patients with idiopathic epilepsy in our study (Table 2) . Majority (57.4%) of these patients are seizurefree and in 13.1% of them antiepileptic medication was withdrawn. Additionally, seizures in the past year were completely controlled in 37.9% of PWE in present study. A much lower percentage (6.9%) of PWE without seizures in the past year was reported by Cramer et al. 6 Several shortcomings of our study have to be noted. One of them is that female subjects predominated; however, the difference between male and female subjects was not statistically significant. A lower QOL in females than in males was found in some 36, 37 but not in all studies. 38 Serbian-language versions of SF-36 and NTS-II have not been psychometrically evaluated yet so we must be aware of this further limitation when interpreting these results. Serbian validation of SF-36 would enable to get norms of QOL for healthy population and for various disease entities and to make meaningful comparison of QOL between PWE and populations with various disease entities. 39 Also, further studies are needed to examine responsiveness of Serbian-language QOLIE-31 to clinical changes, including efficacy and tolerability of the new antiepileptic drugs 11, 14 or epilepsy surgery. 16 
Conclusion
Even with the aforementioned shortcomings, Serbian-language version of QOLIE-31 shows fairly satisfactory psychometric properties-good reliability, high internal consistency, and a high degree of conceptual similarity to the original American version. 6 Therefore, Serbian adaptation of QOLIE-31 may be considered as a reliable and valid questionnaire for further studies of quality of life in PWE.
Appendix A. Structure matrix, after varimax rotation (only items with factor loadings greater than 0.5 are shown) 
